VNDA logo

Vanda Pharmaceuticals (VNDA)

Profile

Full Name

Vanda Pharmaceuticals Inc.

Ticker Symbol

VNDA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 12, 2006

Indexes

Not included

Website

http://www.vandapharma.com

Employees

368

Key Details

Price

$4.38(+0.34%)

Market cap

$255.72M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$198.77M(+3.18% YoY)

Annual EPS

-$0.33(-925.00% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.38
VNDA price is $4.38

30-Day Relative Volume

0.80
VNDA 30-day relative volume is 0.80

Price Performance

Price Today change

+0.34%
VNDA price is up +0.34% today

Price YTD change

-8.46%
VNDA price is down -8.46% since January 1st

Price 1-year change

+8.27%
VNDA price is up +8.27% year-on-year

Price 3-year change

-61.4%
VNDA price is down -61.4% over the past 3 years

Price Range

Price All-time high

$33.44
VNDA price is currently -86.89% below its historical high of $33.44

Price 3-year low

$3.30
VNDA price is currently +32.88% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$255.72M
VNDA market capitalization is $255.72 million

Market cap 3-year change

-60.15%
VNDA market capitalization is down -60.15% over the past 3 years

Market cap All-time high

$1.65B
VNDA market capitalization is currently -84.51% below its historical high of $1.65 billion

Market cap sector rank

61.35%
VNDA market capitalization is higher than 61.35% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.21%
VNDA shares outstanding is up +0.21% year-on-year

Shares Outstanding 3-Year Change

+3.24%
VNDA shares outstanding is up +3.24% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.44
VNDA beta is 0.44

200-day SMA

$4.91
VNDA price is currently -10.75% below its 200-day simple moving average

50-day SMA

$4.63
VNDA price is currently -5.28% below its 50-day simple moving average

RSI

45.12
VNDA 14-day relative strength index is 45.12

Volume

0.80
VNDA 30-day relative volume is 0.80

ATR

$0.22
VNDA average true range is $0.22

10-day Historical Volatility

45.42%
VNDA 10-day historical volatility is 45.42%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$198.77M
VNDA annual revenue is $198.77 million

Revenue Analysts estimate

$222.86M
VNDA annual revenue is currently -10.81% lower than the consensus analysts' forecast

Revenue 1-year change

+3.18%
VNDA annual revenue is up +3.18% year-on-year

Revenue Sector rank

63.69%
VNDA annual revenue is higher than 63.69% of companies in Healthcare sector

EPS

EPS

-$0.33
VNDA annual earnings per share is -$0.33

EPS Analysts estimate

-
VNDA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-925%
VNDA annual earnings per share is down -925% year-on-year

EPS Sector rank

73.49%
VNDA annual earnings per share is higher than 73.49% of companies in Healthcare sector

Profit

Gross profit

$187.46M
VNDA annual gross profit is $187.46 million

Gross margin

94.31%
VNDA annual gross profit margin is 94.31%

Operating profit

-$40.66M
VNDA annual operating income is -$40.66 million

Operating margin

-20.46%
VNDA annual operating profit margin is -20.46%

Net income

-$18.90M
VNDA annual net profit is -$18.90 million

Net margin

-9.51%
VNDA annual net profit margin is -9.51%

Expenses

Total expenses

$239.43M
VNDA annual total expenses is $239.43 million

Operating expenses

$228.12M
VNDA annual total operating expenses is $228.12 million

Cost of goods sold

$11.31M
VNDA annual cost of goods sold is $11.31 million

Selling, general & administrative expenses

$146.41M
VNDA annual SGA is $146.41 million

Depreciation and amortization

$8.13M
VNDA annual depreciation & amortization is $8.13 million

Interest expense

-
VNDA annual interest expense value is unknown

Income tax

-$4.02M
VNDA annual income tax is -$4.02 million

EBIT & EBITDA

EBIT

-$40.66M
VNDA annual earnings before interest & taxes is -$40.66 million

EBITDA

-$32.53M
VNDA annual EBITDA is -$32.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$656.20M
VNDA annual total assets is $656.20 million

Non current assets

$217.31M
VNDA annual long term assets is $217.31 million

Current assets

$438.89M
VNDA annual total current assets is $438.89 million

Cash and cash equivalents

$102.32M
VNDA annual cash & cash equivalents is $102.32 million

Accounts receivable

$47.10M
VNDA annual accounts receivable is $47.10 million

Inventory

$1.73M
VNDA annual inventory is $1.73 million

Liabilities

Total liabilities

$117.66M
VNDA annual total liabilities is $117.66 million

Long term liabilities

$17.68M
VNDA annual total long term liabilities is $17.68 million

Current liabilities

$99.98M
VNDA annual total current liabilities is $99.98 million

Accounts payable

$3.50M
VNDA annual accounts payable is $3.50 million

Debt

Total debt

$12.36M
VNDA annual total debt is $12.36 million

Total debt 1-year change

+31.43%
VNDA annual total debt is up +31.43% year-on-year

Long term debt

$8.09M
VNDA annual long term debt is $8.09 million

Short term debt

$4.27M
VNDA annual short term debt is $4.27 million

Equity & Capital

Shareholders equity

$538.55M
VNDA annual stockholders equity is $538.55 million

Book value

$538.55M
VNDA annual book value is $538.55 million

Retained earnings

-$174.29M
VNDA annual retained earnings is -$174.29 million

Working capital

$338.91M
VNDA annual working capital is $338.91 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.76M
VNDA annual cash flow from operations is -$15.76 million

Cash from operations 1-year change

-223.09%
VNDA annual cash flow from operations is down -223.09% year-on-year

Cash from investing

-$17.43M
VNDA annual cash flow from investing activities is -$17.43 million

Cash from investing 1-year change

-44.58%
VNDA annual cash flow from investing activities is down -44.58% year-on-year

Cash from financing

-$155.00K
VNDA annual cash flow from financing activities is -$155.00 thousand

Cash from financing 1-year change

-100%
VNDA annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

$490.00K
VNDA annual capital expenditures is $490.00 thousand

CAPEX 1-year change

+27.94%
VNDA annual capital expenditures is up +27.94% year-on-year

Free Cash Flow

Free cash flow

-$16.25M
VNDA annual free cash flow is -$16.25 million

Free cash flow 1-year change

-230.83%
VNDA annual free cash flow is down -230.83% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

94.31%
VNDA annual gross profit margin is 94.31%

Operating margin

-20.46%
VNDA annual operating profit margin is -20.46%

Net margin

-9.51%
VNDA annual net profit margin is -9.51%

ROA & ROE

ROA

-2.90%
VNDA annual return on assets is -2.90%

ROE

-3.49%
VNDA annual return on equity is -3.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VNDA price to earnings ratio value is unknown

PE ratio Sector rank

-
VNDA price to earnings ratio is unknown

PB Ratio

PB ratio

0.47
VNDA price to book ratio is 0.47

PB ratio Sector rank

28.97%
VNDA price to book ratio is higher than 28.97% of companies in Healthcare sector

PS Ratio

PS ratio

1.29
VNDA price to sales ratio is 1.29

PS ratio Sector rank

32.05%
VNDA price to sales ratio is higher than 32.05% of companies in Healthcare sector

Enterprise value

Enterprise value

$165.76M
VNDA enterprise value is $165.76 million

Enterprise value Sector rank

56.08%
VNDA enterprise value is higher than 56.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.10
VNDA EV/EBITDA is -5.10

EV/EBITDA Sector rank

18.28%
VNDA EV/EBITDA is higher than 18.28% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.39
VNDA annual current ratio is 4.39

Quick ratio

4.37
VNDA annual quick ratio is 4.37

Leverage

Debt to equity

0.00
VNDA annual debt to equity ratio is 0.00

Interest coverage ratio

-
VNDA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
VNDA piotroski f-score is 3

Altman Z-Score

1.65
VNDA altman z-score is 1.65

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Feb 18, 25 HC Wainwright & Co.
Buy
Feb 4, 25 HC Wainwright & Co.
Buy
Jan 28, 25 HC Wainwright & Co.
Buy
Jan 21, 25 HC Wainwright & Co.
Buy
Dec 23, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Aug 1, 24 Cantor Fitzgerald
Overweight
Jul 11, 24 Cantor Fitzgerald
Overweight
Feb 25, 22 Jefferies
Hold

Institutional Ownership

Similar stocks

AQST logo
Aquestive Therapeutics (AQST)
ZIMV logo
ZimVie (ZIMV)
EBS logo
Emergent BioSolutions (EBS)
NRC logo
National Research (NRC)
HCAT logo
Health Catalyst (HCAT)
TSVT logo
2seventy bio (TSVT)
TSHA logo
Taysha Gene Therapies (TSHA)
XOMA logo
XOMA (XOMA)
MRVI logo
Maravai LifeSciences Holdings (MRVI)
  • What is the ticker symbol for Vanda Pharmaceuticals?
  • Does Vanda Pharmaceuticals pay dividends?
  • What sector is Vanda Pharmaceuticals in?
  • What industry is Vanda Pharmaceuticals in?
  • What country is Vanda Pharmaceuticals based in?
  • When did Vanda Pharmaceuticals go public?
  • Is Vanda Pharmaceuticals in the S&P 500?
  • Is Vanda Pharmaceuticals in the NASDAQ 100?
  • Is Vanda Pharmaceuticals in the Dow Jones?
  • When was Vanda Pharmaceuticals's last earnings report?
  • When does Vanda Pharmaceuticals report earnings?
  • Should I buy Vanda Pharmaceuticals stock now?

What is the ticker symbol for Vanda Pharmaceuticals?

The ticker symbol for Vanda Pharmaceuticals is NASDAQ:VNDA

Does Vanda Pharmaceuticals pay dividends?

No, Vanda Pharmaceuticals does not pay dividends

What sector is Vanda Pharmaceuticals in?

Vanda Pharmaceuticals is in the Healthcare sector

What industry is Vanda Pharmaceuticals in?

Vanda Pharmaceuticals is in the Biotechnology industry

What country is Vanda Pharmaceuticals based in?

Vanda Pharmaceuticals is headquartered in United States

When did Vanda Pharmaceuticals go public?

Vanda Pharmaceuticals's initial public offering (IPO) was on April 12, 2006

Is Vanda Pharmaceuticals in the S&P 500?

No, Vanda Pharmaceuticals is not included in the S&P 500 index

Is Vanda Pharmaceuticals in the NASDAQ 100?

No, Vanda Pharmaceuticals is not included in the NASDAQ 100 index

Is Vanda Pharmaceuticals in the Dow Jones?

No, Vanda Pharmaceuticals is not included in the Dow Jones index

When was Vanda Pharmaceuticals's last earnings report?

Vanda Pharmaceuticals's most recent earnings report was on Feb 13, 2025

When does Vanda Pharmaceuticals report earnings?

The next expected earnings date for Vanda Pharmaceuticals is May 8, 2025

Should I buy Vanda Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page